2 - Pulmonology and Critical Care 2025

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/52

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

53 Terms

1
New cards

FEV1/FVC <0.7

Diagnostic of obstructive pulmonary diseases

2
New cards

TLC <0.8

Diagnostic of restrictive pulmonary diseases

3
New cards

Centrilobular emphysema

Type of emphysema associated with smoking, involving the upper lobes and superior segments of the lower lobes

4
New cards

Panlobular emphysema

Type of emphysema associated with alpha-1 antitrypsin deficiency, involving the lower lobes prominently

5
New cards

Paraseptal emphysema

Type of emphysema associated with inflammation, distributed along pleural margins

6
New cards

Smoking

Major risk factor of COPD

7
New cards

Cough, sputum production, exertional dyspnea

3 most common symptoms of COPD

8
New cards

Wasting

Independent prognostic factor in COPD

9
New cards

Hoover sign (seen in COPD)

Paradoxical inward movement of the ribcage during inspiration

10
New cards

• Lung malignancy

• Bronchiectasis

• Right-to-left shunting from cyanotic heart diseases

• (never COPD)

Conditions presenting with clubbing

11
New cards

Streptococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae

Most common causes of COPD exacerbations

12
New cards

FEV1

Marker of airflow limitation in COPD

13
New cards

• Smoking cessation

• Oxygen therapy in chronically hypoxemia patients

• Lung volume reduction surgery in emphysematous patients

3 interventions with demonstrated decrease in morality among COPD patients

14
New cards

Eosinophils >300 cells/uL in the complete blood count with differential count

An indication for starting inhaled corticosteroids (ICS) for COPD patients

15
New cards

Roflumilast

Add-on therapy in COPD considered for those with FEV1 <0.50 and/or chronic bronchitis

16
New cards

Azithromycin

Add-on therapy in COPD considered for former smokers

17
New cards

Atopy

Major risk factor of asthma

18
New cards

House dust mites

Most common allergen causing perennial asthma

19
New cards

All beta-blockers, Aspirin

Contraindicated drugs in asthma

20
New cards

>12% and 200 mL increase in FEV1 after salbutamol (15 minutes) or oral corticosteroids (2-4 weeks)

Indicator of reversibility in asthma

21
New cards

Inhaled corticosteroids (ICS) + formoterol (LABA)

Preferred controller and reliever medication for asthma

22
New cards

Poor adherence to controller medications

Important cause of exacerbations in asthma

23
New cards

Anaphylaxis

Most common side effect of Omalizumab

24
New cards

3 months

Asthma control is assessed every:

25
New cards

• Pleural fluid adenosine deaminase (>40 IU/L)

• Pleural fluid interferon-gamma (>140 pg/mL)

Tests done to rule out TB pleuritis

26
New cards

NT-proBNP (>1500 pg/mL)

Test done to rule out heart failure causing pleural effusion

27
New cards

Congestive heart failure, Cirrhosis, Nephrotic syndrome, Peritoneal dialysis, Urinothorax, SVC obstruction, Myxedema

Etiologies of transudative pleural effusion

28
New cards

Left ventricular failure

Most common cause of pleural effusion

29
New cards

Left ventricular failure

Most common cause of transudative pleural effusion

30
New cards

Tuberculosis

Most common cause of exudative pleural effusion worldwide

31
New cards

Bacterial pneumonia

Most common cause of exudative pleural effusion in developed nations

32
New cards

Tuberculosis

Most common cause of exudative pleural effusion in developing nations

33
New cards

Lung carcinoma

Breast carcinoma

Lymphoma

3 tumors causing 75% of all malignant pleural effusions

34
New cards

Pulmonary embolism

Most commonly overlooked cause of undiagnosed pleural effusion

35
New cards

Trauma (usually iatrogenic from thoracic surgery) > Mediastinal tumors

Most common cause of chylothorax

36
New cards

• COPD in acute exacerbation

• Pulmonary congestion

Strong indications for noninvasive positive pressure ventilation (NIPPV)

37
New cards

Proliferative phase

Most patients with ARDS recover and are liberated from mechanical ventilation at this phase

38
New cards

Pulmonary fibrosis

Presence of this finding in ARDS patients is associated with increased mortality risk

39
New cards

Low tidal volume

(at most 6 mL/kg PBW)

Only class A recommendation in the management of ARDS

40
New cards

Distributive shock

Only type of shock with increase in cardiac output and decrease in systemic vascular resistance causing "warm extremities"

41
New cards

CNS, kidneys, skin

3 important organ systems in the assessment of a shock patient

42
New cards

Septic shock

Most common cause of distributive shock and the most common form of shock in the ICU and ED

43
New cards

Trauma

Most common cause of external hemorrhage

44
New cards

Gastrointestinal bleeding

Most common cause of internal hemorrhage

45
New cards

Norepinephrine

First-line vasopressor for either septic or cardiogenic shock

46
New cards

Pneumonia

Most common infection causing sepsis in the hospital

47
New cards

Gram-negative bacteria

Most common type of isolate when blood culture is done among septic patients

48
New cards

Diarrheal disease

Most common infection causing sepsis worldwide

49
New cards

Lactated Ringer’s solution 30 mL/kg within the first 3 hours

Recommended fluid resuscitation in a septic patient

50
New cards

At least 65 mmHg

Target mean arterial pressure in a septic shock patient

51
New cards

Norepinephrine

First-line vasopressor in septic shock

52
New cards

Vasopressin

Second-line vasopressor in septic shock

53
New cards

First 1 hour of diagnosis

Empiric antibiotics in septic shock should be initiated within: